Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Jul-23 2:02 PM View:  | Iveric Bio, Inc. (ISEE) | 11-Jul-23 | Disposition | 32,088 | -- | -- | (100%) 32.09K to 0 | |
| 23-Jun-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 22-Jun-23 | Grant | 4,884 | -- | -- | 3% 176.54K to 181.42K | |
| 02-Jun-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 31-May-23 | Grant | 1,640 | -- | -- | < 1% 174.9K to 176.54K | |
| 15-May-23 4:52 PM View: | Iveric Bio, Inc. (ISEE) | 11-May-23 | Option Exercise | 14,588 | -- | -- | 83% 17.5K to 32.09K | |
| 02-Jun-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 10-Mar-23 | Grant | 2,013 | -- | -- | 2% 106.75K to 108.77K | |
| 02-Jun-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 10-Mar-23 | Grant | 66,131 | -- | -- | 61% 108.77K to 174.9K | |
| 24-Feb-23 5:29 PM View: | 1life Healthcare Inc (ONEM) | 22-Feb-23 | Disposition | 4,534 | $18.00 | $81,612.00 | (100%) 4.53K to 0 | |
| 02-Jun-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 15-Feb-23 | Disposition (other) | 3 | -- | -- | (< 1%) 106.83K to 106.82K | |
| 02-Jun-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 15-Feb-23 | Disposition (other) | 70 | -- | -- | (< 1%) 106.82K to 106.75K | |
| 19-Jul-22 4:09 PM View: | Iveric Bio, Inc. (ISEE) | 15-Jul-22 | Option Exercise | 5,000 | -- | -- | 40% 12.5K to 17.5K | |
| 06-Jun-22 8:40 PM View: | 1life Healthcare Inc (ONEM) | 02-Jun-22 | Option Exercise | 4,534 | -- | -- | 100% 0 to 4.53K | |
| 13-May-22 6:02 PM View: | Iveric Bio, Inc. (ISEE) | 11-May-22 | Option Exercise | 7,500 | -- | -- | 150% 5.0K to 12.5K | |
| 17-Nov-21 8:01 PM View: | Kala Bio, Inc. (KALA) | 15-Nov-21 | Grant | 157,765 | -- | -- | 100% 0 to 157.76K | |
| 17-Nov-21 8:01 PM View: | Kala Bio, Inc. (KALA) | 15-Nov-21 | Grant | 5,183,360 | -- | -- | 3285% 157.76K to 5.34M | |
| 19-Jul-21 4:13 PM View: | Iveric Bio, Inc. (ISEE) | 15-Jul-21 | Option Exercise | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 17-Feb-16 5:37 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 12-Feb-16 | Grant | 8,333 | -- | -- | 2% 554.58K to 562.91K | |
| 15-Jun-15 5:01 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 11-Jun-15 | Market Sale (Planned) | 1,900 | $39.97 | $75,939.20 | (< 1%) 556.48K to 554.58K | 67% |
| 11-Jun-15 6:21 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 10-Jun-15 | Market Sale (Planned) | 600 | $39.91 | $23,948.00 | (< 1%) 557.08K to 556.48K | 67% |
| 11-Jun-15 6:21 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 09-Jun-15 | Market Sale (Planned) | 22,500 | $35.75 | $804,328.00 | (4%) 579.58K to 557.08K | 64% |
| 08-Jun-15 5:20 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 05-Jun-15 | Market Sale (Planned) | 5,000 | $40.08 | $200,414.00 | (< 1%) 584.58K to 579.58K | 68% |
| 21-May-15 5:53 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 19-May-15 | Market Sale (Planned) | 3,000 | $36.91 | $110,734.00 | (< 1%) 587.58K to 584.58K | 65% |
| 18-May-15 5:22 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 15-May-15 | Market Sale (Planned) | 22,500 | $35.49 | $798,552.00 | (4%) 610.08K to 587.58K | 63% |
| 13-May-15 7:16 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 13-May-15 | Market Sale (Planned) | 715 | $34.94 | $24,984.20 | (< 1%) 610.8K to 610.08K | 63% |
| 12-May-15 5:00 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 11-May-15 | Market Sale (Planned) | 1,785 | $34.91 | $62,322.60 | (< 1%) 612.58K to 610.8K | 63% |
| 05-May-15 4:06 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 01-May-15 | Market Sale (Planned) | 20,000 | $32.37 | $647,306.00 | (3%) 632.58K to 612.58K | 60% |
| 23-Apr-15 4:56 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 21-Apr-15 | Grant | 2,000 | -- | -- | < 1% 630.58K to 632.58K | |
| 20-Apr-15 5:37 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 16-Apr-15 | Market Sale (Planned) | 25,000 | $41.59 | $1,039,750.00 | (4%) 655.58K to 630.58K | 69% |
| 08-Apr-15 4:47 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 08-Apr-15 | Market Sale (Planned) | 2,500 | $39.94 | $99,840.70 | (< 1%) 658.08K to 655.58K | 67% |
| 08-Apr-15 4:47 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 07-Apr-15 | Market Sale (Planned) | 22,500 | $38.60 | $868,560.00 | (3%) 683.58K to 661.08K | 66% |
| 08-Apr-15 4:47 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 07-Apr-15 | Market Sale (Planned) | 3,000 | $38.60 | $115,808.00 | (< 1%) 661.08K to 658.08K | 66% |
| 18-Mar-15 4:19 PM View: | Presbia Plc (LENS) | 16-Mar-15 | Grant | 9,270 | -- | -- | 100% 0 to 9.27K | |
| 15-Jan-15 4:57 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 13-Jan-15 | Market Sale | 100,000 | $55.46 | $5,546,000.00 | (13%) 783.58K to 683.58K | 77% |
| 07-Aug-14 3:07 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 05-Aug-14 | Conversion | 20,989 | -- | -- | 3% 700.0K to 720.99K | |
| 07-Aug-14 3:07 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 05-Aug-14 | Conversion | 37,593 | -- | -- | 5% 720.99K to 758.58K | |
| 07-Aug-14 3:07 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 05-Aug-14 | Exercise (in-the money or at-the-money) | 25,000 | $0.15 | $3,750.00 | 3% 758.58K to 783.58K |